The Challenge
A small Life Sciences organization had an established product in the Oral CGRP market focused on acute treatment of migraines.
Fifteen months post launch, the brand received an additional indication for the preventative treatment of episodic migraines.
Our Approach and Solution
- Ahead of launch for the acute indication, Propensity4 leveraged market research to understand the attitudes of the HCP population.
- We then correlated attitudes and behaviors demonstrated in claims data to develop a scoring mechanism across the HCP universe and developed targeting for 585 reps to accelerate adoption in acute patients.
- Ahead of the preventative launch, Propensity4 applied our scoring mechanism to identify previously non-targeted HCPs with preventative patients.
- At launch, PROPENSITY4 issued new targeting for the existing and a new preventative indication sales team.
The Results
PROPENSITY4 was able to deliver a final targeting scheme in 8 weeks, marrying primary and secondary data to create an informed targeting approach.
The brand was able to deliver 4x the forecast across both indications in a highly genericized market.
Jump to a slide with the slide dots.
How can AI-powered speech analytics scale call monitoring and improve agent performance?
Discover how Inizio Engage used AI-driven speech analytics to scale call monitoring, enhance agent performance, and improve customer interactions.
Read moreHow DataGateway unified oncology data for real-world insights & market intelligence
A global biopharma company used DataGateway platform to unify complex oncology data into a validated, patient-level dataset - boosting coverage by 80%
Read moreHow can AI-powered call routing transform customer experience and drive operational efficiency?
Discover how an AI-powered Virtual Agent streamlined call routing - reducing manual triage by 50% and enhancing customer experience.
Read more